Pharmacists in Price, Utah


13 Pharmacists found in Price
male pharmacist

Brady Black


Pharmacist
1075 E Main St, Price, UT 84501
435-630-0840     435-637-4628

female pharmacist

Dr. Brooke Nielsen Tabone, PHARMD


Pharmacist
317 E 100 N Ste 4, Price, UT 84501
435-637-6337    

male pharmacist

Dr. Christopher Reid Howes, PHARMD


Pharmacist
610 W Price River Dr, Price, UT 84501
435-637-0806    



female pharmacist

Dr. Cortney Cowley, PHARM. D


Pharmacist
77 S 600 E Rm P, Price, UT 84501
435-604-1034     435-363-0891

female pharmacist

Mrs. Danita K. Stead, PHARM.D.


Pharmacist
255 S Highway 55, Price, UT 84501
435-637-6974     435-637-8557

male pharmacist

Donald Ray Polster, RPH


Pharmacist
300 N Hospital Dr, Price, UT 84501
435-637-4800     435-636-4819

female pharmacist

Kelli Fowles, PHARMD, RPH


Pharmacist
Smith's Food & Drug, 1075 E Main St, Price, UT 84501
435-637-0804     435-637-4628

male pharmacist

Mr. Kenneth Paul Topolovec, RPH


Pharmacist
610 W Price River Dr, Price, UT 84501
435-637-0806     435-637-6153

male pharmacist

Dr. Kenneth Alan Gagnon, PHARM.D.


Pharmacist
300 N Hospital Drive, Price, UT 84501
435-636-4840    

male pharmacist

Mr. Mikel Chad Cowdell, PHARM.D.


Pharmacist
300 N Hospital Dr, Price, UT 84501
435-636-4800    

female pharmacist

Pamela Burt


Pharmacist
255 S Highway 55, Price, UT 84501
435-637-6974     435-637-8557

female pharmacist

Rhonda Raye Ohlin, PHARM D


Pharmacist
610 W Price River Dr, Price, UT 84501
435-637-0806     435-637-6153

male pharmacist

Steven Scow, PHARMD


Pharmacist
1075 E Main St, Price, UT 84501
435-637-0840    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.